AXGN FY 2023 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

FY 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$159M+14.7% YoY

Gross Profit

$122M76.6% margin

Operating Income

-$21M-13.5% margin

Net Income

-$22M-13.7% margin

EPS (Diluted)

$-0.51

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$21M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$197M

Total Liabilities

$101M

Stockholders' Equity

$96M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$159M	$139M	+14.7%
Gross Profit	$122M	$109M	+12.0%
Operating Income	-$21M	-$30M	+27.8%
Net Income	-$22M	-$29M	+25.0%